相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells
Roxane Khoogar et al.
CELLULAR ONCOLOGY (2022)
Epigenetic and Transcriptional Signaling in Ewing Sarcoma-Disease Etiology and Therapeutic Opportunities
Mingli Li et al.
BIOMEDICINES (2022)
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma
David S. Shulman et al.
NPJ PRECISION ONCOLOGY (2022)
Ewing's Sarcoma
Nicolo Riggi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
YAP/TAZ inhibition reduces metastatic potential of Ewing sarcoma cells
Lisa Bierbaumer et al.
ONCOGENESIS (2021)
A first-generation pediatric cancer dependency map
Neekesh Dharia et al.
NATURE GENETICS (2021)
Ewing Sarcoma-Diagnosis, Treatment, Clinical Challenges and Future Perspectives
Stefan K. Zoellner et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Focal adhesion kinase confers pro-migratory and antiapoptotic properties and is a potential therapeutic target in Ewing sarcoma
Konrad Steinestel et al.
MOLECULAR ONCOLOGY (2020)
Transcriptional Programs Define Intratumoral Heterogeneity of Ewing Sarcoma at Single-Cell Resolution
Marie-Ming Aynaud et al.
CELL REPORTS (2020)
RING1B recruits EWSR1-FLI1 and cooperates in the remodeling of chromatin necessary for Ewing sarcoma tumorigenesis
Sara Sanchez-Molina et al.
SCIENCE ADVANCES (2020)
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Class I HDAC inhibitors enhance YB-1 acetylation and oxidative stress to block sarcoma metastasis
Amal M. El-Naggar et al.
EMBO REPORTS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Protein phosphatase 1 regulatory subunit 1A in ewing sarcoma tumorigenesis and metastasis
W. Luo et al.
ONCOGENE (2018)
Reactivation of TWIST1 contributes to Ewing sarcoma metastasis
Sun Choo et al.
PEDIATRIC BLOOD & CANCER (2018)
Mechanisms of receptor tyrosine kinase activation in cancer
Zhenfang Du et al.
MOLECULAR CANCER (2018)
Ewing sarcoma
Thomas G. P. Gruenewald et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
Epigenome editing of microsatellite repeats defines tumor-specific enhancer functions and dependencies
Gaylor Boulay et al.
GENES & DEVELOPMENT (2018)
The endochondral bone protein CHM1 sustains an undifferentiated, invasive phenotype, promoting lung metastasis in Ewing sarcoma
Kristina von Heyking et al.
MOLECULAR ONCOLOGY (2017)
DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma
Nathan C. Sheffield et al.
NATURE MEDICINE (2017)
Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells
G-A Franzetti et al.
ONCOGENE (2017)
EWS-FLI1 perturbs MRTFB/YAP-1/TEAD target gene regulation inhibiting cytoskeletal autoregulatory feedback in Ewing sarcoma
A. M. Katschnig et al.
ONCOGENE (2017)
The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis
M. Sechler et al.
ONCOGENE (2017)
Identification of two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma
Kirsten M. Johnson et al.
PLOS ONE (2017)
Role for the EWS domain of EWS/FLI in binding GGAA-microsatellites required for Ewing sarcoma anchorage independent growth
Kirsten M. Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain
Gaylor Boulay et al.
CELL (2017)
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Roel Nusse et al.
CELL (2017)
Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease
Jenny Potratz et al.
MOLECULAR ONCOLOGY (2016)
Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy
Laurens G. L. Sand et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States
Elisabeth A. Pedersen et al.
CANCER RESEARCH (2016)
RING1B contributes to Ewing sarcoma development by repressing the NaV1.6 sodium channel and the NF-κB pathway, independently of the fusion oncoprotein
Inmaculada Hernandez-Munoz et al.
ONCOTARGET (2016)
Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
Laura Lagares-Tena et al.
ONCOTARGET (2016)
Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma
Kelly M. Bailey et al.
NEOPLASIA (2016)
Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis
Amal M. El-Naggar et al.
CANCER CELL (2015)
Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma
Konstantin Agelopoulos et al.
CLINICAL CANCER RESEARCH (2015)
YAP/TAZ for cancer therapy: Opportunities and challenges
Liwen Guo et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
EWS-FLI1 employs an E2F switch to drive target gene expression
Raphaela Schwentner et al.
NUCLEIC ACIDS RESEARCH (2015)
Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1
Eleni M. Tomazou et al.
CELL REPORTS (2015)
Gene expression profiling of Ewing sarcoma tumours reveals the prognostic importance of tumour-stromal interactions: a report from the Children's Oncology Group
Samuel L. Volchenboum et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2015)
EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma
Nicolo Riggi et al.
CANCER CELL (2014)
Reversible LSD1 Inhibition Interferes with Global EWS/ETS Transcriptional Activity and Impedes Ewing Sarcoma Tumor Growth
Savita Sankar et al.
CLINICAL CANCER RESEARCH (2014)
Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors
Miwa Tanaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Stress-Induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma
Melanie A. Krook et al.
MOLECULAR CANCER RESEARCH (2014)
The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment
Randy Johnson et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
The Genomic Landscape of Pediatric Ewing Sarcoma
Brian D. Crompton et al.
CANCER DISCOVERY (2014)
DKK2 Mediates Osteolysis, Invasiveness, and Metastatic Spread in Ewing Sarcoma
Kristina Hauer et al.
CANCER RESEARCH (2013)
ERBB4 confers metastatic capacity in Ewing sarcoma
Ariadna Mendoza-Naranjo et al.
EMBO MOLECULAR MEDICINE (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
LGR5 is expressed by Ewing sarcoma and potentiates Wnt/beta-catenin signaling
Christopher A. Scannell et al.
FRONTIERS IN ONCOLOGY (2013)
Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression
Zhe Jin et al.
BMC CANCER (2012)
Wnt/β-Catenin Signaling and Disease
Hans Clevers et al.
CELL (2012)
Identification and quantification of newly synthesized proteins translationally regulated by YB-1 using a novel Click–SILAC approach
Syam Prakash Somasekharan et al.
Journal of Proteomics (2012)
1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma
C. Mackintosh et al.
ONCOGENE (2012)
Microsatellites with Macro-Influence in Ewing Sarcoma
Michael J. Monument et al.
GENES (2012)
The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease
Dagmar Berghuis et al.
CLINICAL SARCOMA RESEARCH (2012)
Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor
Helen J. Knowles et al.
BMC CANCER (2010)
Basic fibroblast growth factor in the bone microenvironment enhances cell motility and invasion of Ewing's sarcoma family of tumours by activating the FGFR1-PI3K-Rac1 pathway
S. Kamura et al.
BRITISH JOURNAL OF CANCER (2010)
Xg Expression in Ewing's Sarcoma Is of Prognostic Value and Contributes to Tumor Invasiveness
Ophelie Meynet et al.
CANCER RESEARCH (2010)
Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells In vitro
Dave N. T. Aryee et al.
CANCER RESEARCH (2010)
Cell Signaling by Receptor Tyrosine Kinases
Mark A. Lemmon et al.
CELL (2010)
Intercohort Gene Expression Co-Analysis Reveals Chemokine Receptors as Prognostic Indicators in Ewing's Sarcoma
Idriss M. Bennani-Baiti et al.
CLINICAL CANCER RESEARCH (2010)
Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP)
Diana Zambelli et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis
Anna Rocchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize
Miguel Sainz-Jaspeado et al.
MOLECULAR CANCER RESEARCH (2010)
Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase
H. Yamamoto et al.
ONCOGENE (2010)
Recent advances in the molecular pathogenesis of Ewing's sarcoma
E. C. Toomey et al.
ONCOGENE (2010)
Translational Activation of Snail1 and Other Developmentally Regulated Transcription Factors by YB-1 Promotes an Epithelial-Mesenchymal Transition
Valentina Evdokimova et al.
CANCER CELL (2009)
Reduced proliferation and enhanced migration: Two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1
Valentina Evdokimova et al.
CELL CYCLE (2009)
A high proportion of bone marrow T cells with regulatory phenotype (CD4+CD25hiFoxP3+) in Ewing sarcoma patients is associated with metastatic disease
Peter Brinkrolf et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Y-Box-Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy
Oleg Gluz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology
Persoulla Nicolaou et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
The Oncogenic EWS-FLI1 Protein Binds In Vivo GGAA Microsatellite Sequences with Potential Transcriptional Activation Function (Publication with Expression of Concern. See vol. 17, 2022)
Noelle Guillon et al.
PLOS ONE (2009)
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
Guenther H. S. Richter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phosphorylated Caveolin-1 Regulates Rho/ROCK-Dependent Focal Adhesion Dynamics and Tumor Cell Migration and Invasion
Bharat Joshi et al.
CANCER RESEARCH (2008)
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells
Siew Wee Chan et al.
CANCER RESEARCH (2008)
The role of hypoxia-inducible factors in tumorigenesis
E. B. Rankin et al.
CELL DEATH AND DIFFERENTIATION (2008)
Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy
Karl-Ludwig Schaefer et al.
EUROPEAN JOURNAL OF CANCER (2008)
Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor
Krishna Reddy et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Hypoxia in cancer: significance and impact on clinical outcome
Peter Vaupel et al.
CANCER AND METASTASIS REVIEWS (2007)
Caveolin-1 (CAV1) is a target of EWS/FLI-1 and a key determinant of the oncogenic phenotype and tumorigenicity of Ewing's sarcoma cells
Oscar M. Tirado et al.
CANCER RESEARCH (2006)
CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment
JA Burger et al.
BLOOD (2006)
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia
DWJ van der Schaft et al.
CANCER RESEARCH (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
The actin cytoskeleton-associated protein zyxin acts as a tumor suppressor in Ewing tumor cells
V Amsellem et al.
EXPERIMENTAL CELL RESEARCH (2005)
Prediction of high risk Ewing's sarcoma by gene expression profiling
A Ohali et al.
ONCOGENE (2004)
DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets
MS Staege et al.
CANCER RESEARCH (2004)
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4
F Marchesi et al.
CANCER RESEARCH (2004)
YB-11s upregulated during prostate cancer tumor progression and increases P-glycoprotein activity
P Giménez-Bonafé et al.
PROSTATE (2004)
Are 90K/MAC-2BP serum levels correlated with poor prognosis in HCC patients? Preliminary results
PA Iacovazzi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2003)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
分享论文
